Champions Oncology, Inc.
20.10.2021 16:28:12 CEST | ACCESS Newswire | Press release
HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced the opening of a European laboratory located in the renowned OpenZone Life Sciences Campus in Bresso, Italy, on the doorstep of Milan.
After launching preclinical and clinical GCLP-compliant biomarker services in 2019, Champions Oncology has rapidly grown to be a leader in the industry by providing scientific expertise, unparalleled quality, and innovative data analytics.
OpenZone is a scientific campus conceived by the healthcare company Zambon to create value in the field of Health, by fostering community, competencies, and capital. With the arrival of Champions Oncology, it is home to 34 enterprises and is undergoing a substantial expansion phase. Thanks to a total investment of around 65 million euros, OpenZone will double in size by 2022, growing to cover a surface area of 37,000 square meters with the capacity to host up to 1,200 people.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page."Expanding our laboratory footprint into Europe is a tremendous milestone for Champions," said Ronnie Morris, MD, CEO of Champions Oncology. "Having local/regional access to clinical trial patient samples, some which require less than 24 hours to be processed to achieve accurate readouts, will provide a solution to our clients and also drive growth for our clinical biomarker business in the years to come."
With the unprecedented growth of clinical trials in Europe and the requirement of proximity to access expert biomarker analytical services, Champions is well positioned to serve existing as well as new European clients within the Biotech and Pharmaceutical industries with its expertise in high-dimensional flow cytometry (up to 24-colors) and other analytical techniques as part of Champions' growing portfolio.
About Champions Oncology, Inc.
Champions Oncology is a data-driven research organization, with headquarters in the United States, that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computational-based discovery platforms, unique oncology software solutions, and innovative and proprietary experimental tools such as in vivo, ex-vivo and biomarker platforms. For more information, please visit www.ChampionsOncology.com.
Media Contact:
Rachel Bunting, MS, MBA
Sr. Director, Head of Marketing
Champions Oncology, Inc.
Marketing@championsoncology.com
About OpenZone
OpenZone is the campus, on the doorstep of Milan, dedicated to Health and founded on an approach geared towards open innovation. Conceived by the healthcare company Zambon to build bridges between different languages and worlds, OpenZone mission is to "uniquely create value in Healthcare, by fostering community, competencies and capital". Today the campus is home to 34 enterprises, including some of the foremost biotechnology, pharmaceutical and advanced gene therapy companies, all with a strong penchant for innovation. Work is underway to expand the campus, which, thanks to a total investment of around 65 million euros, will double in size by 2022, growing to cover a surface area of 37,000 square metres, with the capacity to host up to 1,200 people.
OpenZone works closely with all stakeholders in the health sector, to ensure that Milan and Lombardy are increasingly recognized internationally as a territory of excellence for life sciences. Learn more on www.openzone.it/en.
Media Contacts:
Marco Allegrini
Tel: +39 347 339 5615
E: marco.allegrini@zambongroup.com
E: ufficiostampa@openzone.it
Image Building
Cristina Fossati / Angela Fumis
Tel. +39 02 89011300
E: zambon@imagebuilding.it
SOURCE: Champions Oncology, Inc.
View source version on accesswire.com:
https://www.accesswire.com/668789/Champions-Oncology-Expands-Global-Biomarker-Capabilities-with-Opening-of-European-Laboratory-at-OpenZone-Life-Sciences-Campus
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Powerverse and Teltonika Energy Partner to Unlock Intelligent Home Energy & Flexibility19.3.2026 08:00:00 CET | Press release
LONDON, UK / ACCESS Newswire / March 19, 2026 / Powerverse has partnered with Teltonika Energy, part of the Teltonika group, a multinational leader in IoT innovation, to deliver an AI-driven home energy ecosystem that enhances user experience, unlocks flexibility services and drives long-term customer value. Teltonika Energy's hardware is built with reliability, connectivity and performance at its core, and its devices are designed to support the next generation of intelligent home energy systems. "Teltonika Energy is globally recognised for its high-quality, IoT-engineered hardware," said Richard Britton, CEO of Powerverse. "We are thrilled to combine their robust devices with our AI-driven platform to help customers move beyond simple smart control and into active market participation. Together, we are delivering a fully integrated, end-to-end solution that makes it effortless for users to lower costs, reduce their carbon footprint, and unlock the full long-term value of home energy
Affiliate of Pacific Avenue Capital Partners Completes Acquisition of Care.com from IAC18.3.2026 23:45:00 CET | Press release
LOS ANGELES, CA / ACCESS Newswire / March 18, 2026 / Pacific Avenue Capital Partners ("Pacific Avenue"), a Los Angeles-headquartered private equity firm focused on corporate carve-outs and other complex transactions in the middle market, today announced that an affiliate of Pacific Avenue has completed the acquisition of Care.com from IAC Inc. (NASDAQ: IAC). Care.com is a leading platform and brand in the growing $400 billion market for family care, anchored by the largest online network of background-checked child and senior caregivers in the U.S. Care.com operates both a scaled consumer marketplace and an enterprise benefits platform. Since 2007, more than 45 million people have turned to Care.com to find child care, senior care, pet care and housekeeping support. Care.com also partners with more than 700 employers, including many of the Fortune 100, to deliver care-related benefits that combine access to the Care.com platform and comprehensive backup care solutions provided in-home,
Maxon Marks Its Official Entry Into the AEC Market With Its Real-Time Archviz Solution17.3.2026 15:05:00 CET | Press release
Redshift for Vectorworks now available, Autodesk Revit® beta open for sign-ups, and Graphisoft Archicad releasing later in 2026. Maxon unveils a deeper look at its end-to-end 3D workflow for architects and designers in 2026 and beyond. BAD HOMBURG, DE / ACCESS Newswire / March 17, 2026 / Maxon, maker of powerful, approachable software solutions for creators working in 2D and 3D design, motion graphics, visual effects, gaming, and more, today announced the commercial availability of Redshift for Vectorworks. Additionally, the company announced the beta launch of Redshift for Autodesk Revit®. This marks the next major milestone in Maxon's expansion into the Architecture, Engineering & Construction (AEC) market, with additional integrations planned. Engineered for architects and interior designers, Maxon's AEC solution brings the company's industry-proven cinematic rendering technology, Redshift, and the creative depth of Cinema 4D directly into professional archviz workflows. Designed as
Sauce Labs CEO, Prince Kohli, Says $1 Trillion Software Quality Industry Has Been "Building Wrong" for 20 Years17.3.2026 15:00:00 CET | Press release
The new Sauce AI for Test Authoring launch targets the most labor-intensive slice of the 22% of IT budgets spent on quality assurance, by shifting engineering teams from writing test cases to specifying business intent that the platform autonomously turns into self-improving test suites. SAN FRANCISCO, CA / ACCESS Newswire / March 17, 2026 / Sauce Labs Inc., the world's largest full-lifecycle, test automation platform, today announced the general availability of Sauce AI for Test Authoring, an AI Agent that translates business intent into framework-agnostic executable test suites that can be run instantly on Sauce Labs' virtual and real-device clouds. This launch introduces a new paradigm for DevOps: Intent-Driven Testing, designed to bridge the "Velocity and Quality Gap", the widening distance between how fast AI generates code and how slowly teams can validate it for enterprise-grade quality. High-quality test creation is one of software development's most persistent bottlenecks. Dev
Datavault AI Schedules Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 202617.3.2026 12:00:00 CET | Press release
PHILADELPHIA, PA / ACCESS Newswire / March 17, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real‑world asset tokenization technologies, today announced that it will report financial results for its fourth quarter and full year 2025 prior to market open on Thursday, March 19, 2026. Following the release, Datavault AI will conduct a conference call and live webcast on the same day, at 8:30 a.m. ET. Conference Call and Webcast Information Date: Thursday, March 19, 2026, at 8:30 a.m. ET Participant Dial-in (US): 1-877-405-1216 Participant Dial-in (International): 1-201-689-8336 Webcast Access: Click Here Datavault AI CEO, Nathaniel Bradley, and CFO Brett Moyer, will be presenting. A replay of the webcast will be made available later in the day in the Investors/Presentations section of the Datavault AI website: Click Here. About Datavault AI Inc. Datavault AI TM (NASDAQ:DVLT) is leading the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom